Acknowledgements
Cancer
FOX, CANCER
First and foremost, we thank the patients, their families, their medical teams and all study sites that participated in the iMATRIX-atezolizumab study, which was sponsored by Genentech and F. Hoffmann-La Roche. This work was supported primarily by a Terry Fox New Investigator Award to T.J.P. Additional funding support for the project was made possible by the Princess Margaret Cancer Foundation, Ontario Institute for Cancer Research and Terry Fox Research Institute. T.J.P. holds the Canada Research Chair in Translational Genomics and is supported by a Senior Investigator Award from the Ontario Institute for Cancer Research and the Gattuso-Slaight Personalized Cancer Medicine Fund. A.N. was supported by a Princess Margaret Postdoctoral Fellowship. We gratefully acknowledge the individuals from the Princess Margaret Genomics Centre (